Ja. Bond et al., p53-dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with P-32 ortho-phosphate in human fibroblasts, ONCOGENE, 18(25), 1999, pp. 3788-3792
The tumour suppressor gene p53 plays a major role in the cellular response
to DNA damage, mediating growth arrest and/or apoptosis. Phosphorylation of
the protein occurs at numerous sites ill vivo and is likely to be a major
mechanism for modulation of its activity as a transcriptional transactivato
r. Not surprisingly, therefore, p53 has been intensively studied by P-32 me
tabolic labelling. Here we show however, using normal human fibroblasts, th
at typical labelling conditions induce (i) a p53-dependent inhibition of DN
A synthesis and (ii) an increase in the cellular content of p53 protein det
ectable by the phosphorylation-sensitive antibody DO-1 but not by antibody
DO-12. These data demonstrate for the first time that P-32 labelling is suf
ficient to induce biologically-significant, p53-mediated cellular response
and strongly suggest that it perturbs the phosphorylation state of p53 whic
h it is being used to measure. This highlights the need to re-evaluate earl
ier data by nonradioactive approaches using phospho-specific antibodies.